
Coffee, caffeine not tied to psoriasis
A new study suggests that coffee and caffeine are not associated with psoriasis incidence after adjustment for smoking.
Boston - A new study suggests that coffee and caffeine are not associated with psoriasis incidence after adjustment for smoking.
Wenqing Li, Ph.D., of Brigham and Women’s Hospital and Harvard Medical School, and colleagues report in a
HealthDay News reports that during 1,140,758 person-years of follow-up, the researchers identified 986 incident cases of psoriasis, and that in an age-adjusted model, the risk of psoriasis increased moderately as coffee consumption increased. The association was no longer significant after adjustment for smoking.
The association between decaffeinated coffee and the risk of psoriasis was not significant.
“We did not observe a material change of psoriasis incidence associated with coffee or caffeine intake, after adjusting for known confounders,” the authors wrote. “Smoking appears to be the major confounder underlying the observed significant association between coffee and caffeine intake and risk of psoriasis in age-adjusted models.”
The research letter appears in the March issue of the
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















